A SUBCUTANEOUSLY ADMINISTERED RNAI THERAPEUTIC (ALN-CC5) TARGETING COMPLEMENT C5 FOR TREATMENT OF PNH AND COMPLEMENT MEDIATED DISEASES: INTERIM PHASE 1 STUDY RESULTS IN HEALTHY VOLUNTEERS

EHA Library, Benny Sorensen, 103180

CALCIUM INFLUX IS SHAPED BY THE MUTATIONAL STATUS IN CIRCULATING CD34+ CELLS OF PATIENTS WITH MYELOFIBROSIS

EHA Library, Vittorio Rosti, 103163

RESULTS OF A FIRST-IN-HUMAN, PHASE 1/2 TRIAL OF ASP2215, A SELECTIVE, POTENT ORAL INHIBITOR OF FLT3/AXL, IN PATIENTS WITH RELAPSED OR REFRACTORY ACUTE MYELOID LEUKEMIA

EHA Library, Regina switzer, 103407

OVERALL SURVIVAL ANALYSIS ADJUSTING FOR TREATMENT EFFECT AFTER CROSSOVER IN A PHASE 3 STUDY EVALUATING IDELALISIB IN COMBINATION WITH RITUXIMAB IN RELAPSED CHRONIC LYMPHOCYTIC LEUKEMIA (CLL)

EHA Library, Paolo Ghia, 103166

COMBINATION OF MINOR PAROXYSMAL NOCTURNAL HEMOGLOBINURIA CLONES AND LYMPHOCYTE TELOMERE LENGTH PREDICT RESPONSIVENESS TO IMMUNOSUPPRESSIVE THERAPY IN PEDIATRIC APLASTIC ANEMIA

EHA Library, Atsushi Narita, 103409

POST-TRANSPLANT CARFILZOMIB (KYPROLIS

EHA Library, Andrzej J. Jakubowiak, 103224

ASSOCIATION OF MIR29 RNA WITH RESPONSE AND SURVIVAL IN OLDER PATIENTS WITH ACUTE MYELOID LEUKEMIA (AML) TREATED WITH AZACITIDINE (AZA) OR CONVENTIONAL CARE REGIMENS (CCR)

EHA Library, Kyle J.MacBeth, 103171

DONOR-DERIVED, CD19-DIRECTED, CAR-MODIFIED T CELLS INFUSED AFTER ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION AS PRE-EMPTIVE DONOR LYMPHOCYTE INFUSION IN PATIENTS WITH CD19+ MALIGNANCIES

EHA Library, Partow Kebriaei, 103162

IMPACT OF MAJOR ROUTE VERSUS UNBALANCED MINOR ROUTE KARYOTYPES AT DIAGNOSIS ON PROGNOSIS OF CML

EHA Library, Christian T.Dietz, 103147

THE LLR TAP ICICLLE TRIAL ASSESSING BIOLOGICAL RESPONSE TO IBRUTINIB IN CLL: IMMEDIATE DISEASE REDISTRIBUTION PRECEDES CELL CYCLE ARREST BY 2 WEEKS WITH REDUCED BONE MARROW INFILTRATION BY 6 MONTHS.

EHA Library, Andy Rawstron, 103132

CONCURRENT CREBBP AND KRAS MUTATIONS ARE ASSOCIATED WITH A DISMAL OUTCOME IN CHILDREN WITH HYPERDIPLOID LEUKEMIA IMPLYING A SYNERGISTIC FUNCTION IN RELAPSE EVOLUTION

EHA Library, Renate Panzer-Grumayer, 103102

CONSTITUTUIONAL GENETIC VARIATION AT HBS1L-MYB INFLUENCES WHETHER JAK2 V617F MUTATED MPN PRESENT WITH PV OR ET

EHA Library, William Tapper, 103076

MULTIVARIATE ANALYSIS OF PFS FROM THE AETHERA TRIAL: A PHASE 3 STUDY OF BRENTUXIMAB VEDOTIN CONSOLIDATION AFTER AUTOLOGOUS STEM CELL TRANSPLANT FOR HL

EHA Library, Jan Walewski, 103064

LOW IKZF1 EXPRESSION IS ASSOCIATED WITH FAVORABLE OUTCOME IN LENALIDOMIDE TREATED NEWLY DIAGNOSED MULTIPLE MYELOMA

EHA Library, Christian Langer, 103227

THE THROMBOPOIETIN RECEPTOR SUPPORTS PROLONGED JAK2 V617F DIMERIZATION AND ACTIVATION AND IS MORE SENSITIVE TO LOW JAK2 V617F LEVELS DUE TO LONG HALF-LIFE WHEN COMPARED TO EPOR AND G-CSFR

EHA Library, Vitalina Gryshkova, 103198

BENDAMUSTINE-CONTAINING REGIMEN (BEGEV) AS INDUCTION CHEMOTHERAPY PRIOR TO ASCT FOR RELAPSED/REFRACTORY HODGKIN LYMPHOMA

EHA Library, Rita Mazza, 103195

EAC BCR-ABL1 ASSAY PERFORMANCE VALIDATION ON THE DPCR QS3D PLATFORM AND COMPARISON WITH OTHER DPCR PLATFORMS.

EHA Library, Alikian Mary, 103233

ELTROMBOPAG ADDED TO STANDARD IMMUNOSUPPRESSION AS FIRST TREATMENT IN SEVERE APLASTIC ANEMIA

EHA Library, Danielle Townsley, 103174

AKT PHOSPHORYLATION AT SERINE 473 IS A POWERFUL NOVEL BIOMARKER IN ACUTE MYELOID LEUKAEMIA, AND IS RELATED TO PROTEIN PHOSPHATASE 2A (PP2A) INHIBITION BY CIP2A AND SETBP1

EHA Library, Richard Clark, 103172

IMMUNOMODULATORY EFFECT OF VITAMIN D AFTER ALLOGENEIC STEM CELL TRANSPLANTATION (ALLOSCT): RESULTS OF A PROSPECTIVE MULTICENTER CLINICALTRIAL. ALOVITA; EUDRACT: 2010-023279-25

EHA Library, Jose Antonio Perez-Simon, 103170

THE INTERNATIONAL PROGNOSTIC INDEX FOR PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA (CLL-IPI) – AN INTERNATIONAL META-ANALYSIS

EHA Library, Jasmin Bahlo, 103401

MEK AND PI3K-AKT INHIBITORS SYNERGISTICALLY TARGET HYPERACTIVATING IL7-RECEPTOR SIGNALING MUTATIONS IN T-CELL ACUTE LEUKEMIA

EHA Library, Kirsten Canté-Barrett, 103101

IBRUTINIB IN PREVIOUSLY TREATED PATIENTS WITH WALDENSTR

EHA Library, Steven Treon, 103223

MONOTHERAPY TREATMENT WITH A SINGLE DOSE OF THE CXCR4 ANTAGONIST BL-8040 AS A NOVEL METHOD FOR MOBILIZATION OF HUMAN HSPC AND MSC; RESULTS OF A PHASE I HEALTHY VOLUNTEERS STUDY

EHA Library, Yaron Pereg, 103210

IDENTIFICATION OF FIP1L1-PDGFRA ASSOCIATING MOLECULE THAT LOCATES IN THE NUCLEUS AND AUGMENTS THE ACTIVITY OF FIP1L1-PDGFRA.

EHA Library, Takeshi Kondo, 103205

SAFETY AND EFFICACY OF THE BRUTON TYROSINE KINASE INHIBITOR IBRUTINIB IN PATIENTS WITH HAIRY CELL LEUKEMIA: INTERIM RESULTS OF A PHASE 2 STUDY

EHA Library, Jeffrey Jones, 103204

PREDICTORS OF DEEP MOLECULAR RESPONSE IN CHRONIC MYELOID LEUKEMIA PATIENTS TREATED FRONTLINE WITH IMATINIB MESYLATE: AN ANALYSIS BY THE GIMEMA CML WP

EHA Library, Fausto Castagnetti, 103193

GERMAN HODGKIN STUDY GROUP PHASE I TRIAL OF DOXORUBICIN, VINBLASTINE, DACARBAZINE, AND LENALIDOMIDE (AVD-REV) FOR ELDERLY HODGKIN LYMPHOMA PATIENTS ? FINAL ANALYSIS

EHA Library, Boris Böll, 103189

COMPREHENSIVE GENOMIC PROFILING OF A LARGE COHORT OF ACUTE MYELOID LEUKAEMIA TO DISSECT ITS GENOMIC AND PHENOTYPIC COMPLEXITY

EHA Library, Elli Papaemmanuil, 103179

A FUNDAMENTAL ROLE OF CXCR4 IN T-ACUTE LYMPHOBLASTIC LEUKEMIA

EHA Library, Diana Passaro, 103408

CELLULAR AND MOLECULAR CHARACTERIZATION OF ERYTHROID DEFECTS IN DIAMOND BLACKFAN ANEMIA

EHA Library, David Bodine, 103084

OVEREXPRESSION OF INTEGRIN Α9 COOPERATES WITH THE LOSS OF RUNX1 AND RUNX3 IN LEUKEMOGENESIS

EHA Library, Desmond Chin, 100693

EUROPEAN NETWORK NGS-PTL PRELIMINARY DATA: WHOLE EXOME SEQUENCING IDENTIFIES MUTATIONS OF ALDH2, RETSAT, HSPG2, CHPF, AND OTHER METABOLIC GENES AS A NOVEL FUNCTIONAL CATEGORY IN ACUTE MYELOID LEUKEMIA

EHA Library, Giorgia Simonetti, 100694

THE PAN-CLASS I PI3 KINASE INHIBITOR, NVP-BKM120, DEMONSTRATES ANTI-LEUKEMIC ACTIVITY IN ACUTE MYELOID LEUKEMIA

EHA Library, Matteo Allegretti, 100695

ACUTE MYELOID LEUKEMIA DERIVED MACROPHAGE MIGRATION INHIBITORY FACTOR DRIVES INTERLEUKIN-8 PRO-SURVIVAL SIGNALS IN THE TUMOR MICROENVIRONMENT

EHA Library, Amina Abdul-Aziz, 100696

XPO1 INHIBITION USING SELINEXOR SYNERGIZES WITH CHEMOTHERAPY IN ACUTE MYELOID LEUKEMIA (AML) BY TARGETING DNA REPAIR GENES

EHA Library, Ramiro Garzon, 100697

MAPPING WHOLE-EXOME SEQUENCING DATA OF ACUTE MYELOID LEUKEMIA PATIENTS INTO KEGG PATHWAYS

EHA Library, Antonella Padella, 100698

PBX3 AND MEIS1 COOPERATE THROUGH MULTIPLE MECHANISMS TO SUPPORT HOX-INDUCED MURINE LEUKEMIA

EHA Library, Robert Slany, 100699

THE MODULAR NETWORK STRUCTURE OF THE MUTATIONAL LANDSCAPE OF ACUTE MYELOID LEUKEMIA

EHA Library, Mariam Ibañez, 100700

INVESTIGATING THE ROLE OF BONE MARROW ADIPOCYTES IN REGULATING SURVIVAL AND PROLIFERATION OF ACUTE MYELOID LEUKEMIA

EHA Library, Manar Shafat, 100701

COMPARATIVE FUNCTIONAL ANALYSIS OF THE MOLECULAR NETWORK OF 7 SELECTED MLL FUSION PROTEINS

EHA Library, Anna Skucha, 100702

RETINOIC ACID AND ARSENIC TRIOXIDE TRIGGER DEGRADATION OF MUTATED NPM-1 RESULTING IN APOPTOSIS OF AML CELLS

EHA Library, Ali Bazarbachi, 100703

CLINICAL SAFETY AND ACTIVITY OF AG-120, A FIRST-IN-CLASS, POTENT INHIBITOR OF THE IDH1 MUTANT PROTEIN, IN A PHASE 1 STUDY OF PATIENTS WITH ADVANCED IDH1-MUTANT HEMATOLOGIC MALIGNANCIES

EHA Library, Stéphane deBotton, 100704

TOSEDOSTAT PLUS LOW DOSE CYTARABINE COMBO INDUCES A HIGH RATE OF RESPONSES THAT CAN BE PREDICTED BY GENETIC PROFILING IN AML: FINAL RESULTS OF A PHASE II MULTICENTER STUDY

EHA Library, Giuseppe Visani, 100705

LOW-DOSE LENALIDOMIDE AND CYTARABINE COMBO PRODUCES A HIGH COMPLETE REMISSION RATE THAT CAN BE PREDICTED BY GENETIC PROFILING IN AML PATIENTS AGED ≥70 YEARS: FINAL RESULTS OF A PHASE II STUDY.

EHA Library, Alessandro Isidori, 100706

OVERALL SURVIVAL (OS) AND CLINICAL OUTCOMES IN OLDER PATIENTS WITH ACUTE MYELOID LEUKEMIA (AML) TREATED WITH AZACITIDINE (AZA) OR INTENSIVE CHEMOTHERAPY (IC) IN THE AZA-AML-001 STUDY

EHA Library, Hartmut Döhner, 100707

UPDATED RESULTS FROM A PHASE 2 STUDY OF PRACINOSTAT (P) IN COMBINATION WITH AZACITIDINE (AZA) IN ELDERLY PATIENTS WITH ACUTE MYELOID LEUKEMIA (AML)

EHA Library, Guillermo Garcia-Manero, 100709

AG-221, AN ORAL, SELECTIVE, FIRST-IN-CLASS, POTENT INHIBITOR OF THE IDH2 MUTANT ENZYME, INDUCED DURABLE RESPONSES IN A PHASE 1 STUDY OF IDH2 MUTATION-POSITIVE ADVANCED HEMATOLOGIC MALIGNANCIES

EHA Library, Courtney DiNardo, 100710

ORAL TETRA-ARSENIC TETRA-SULFIDE FORMULA IS BETTER THAN INTRAVENOUS ARSENIC TRIOXIDE IN TREATING ACUTE PROMYELOCYTIC LEUKEMIA:A SYSTEMATIC REVIEW AND META-ANALYSIS OF RANDOMIZED CONTROLLED TRIALS

EHA Library, Gan-Lin He, 100711

LATE RESPONSES AND OVERALL SURVIVAL (OS) FROM LONG TERM FOLLOW UP OF A RANDOMIZED PHASE 2 STUDY OF SGI-110 (GUADECITABINE) 5-DAY REGIMEN IN ELDERLY AML WHO ARE NOT ELIGIBLE FOR INTENSIVE CHEMOTHERAPY

EHA Library, Patricia Kropf, 100712

SPHINGOSINE KINASES ARE REQUIRED FOR IL-7-MEDIATED SIGNALING IN T-CELL ACUTE LYMPHOBLASTIC LEUKEMIA

EHA Library, Alice Melão, 100662

CHARACTERISATION OF TP53 MUTATIONS IN ADULT ACUTE MYELOID LEUKEMIA (AML) PATIENTS: MUTUAL EXCLUSIVITY WITH FLT3 AND NPM MUTATIONS STRONG ASSOCIATION WITH COMPLEX KARYOTYPE AND POOR OUTCOME

EHA Library, Anna Ferrari, 100714

PHASE 1 TRIAL OF G-CSF, CLADRIBINE, CYTARABINE, AND DOSE-ESCALATED MITOXANTRONE (G-CLAM) IN ADULTS WITH NEWLY DIAGNOSED AML OR HIGH-RISK MDS

EHA Library, Asma Anwar, 100715

OVERALL SURVIVAL (OS) WITHOUT COMPLETE REMISSION (CR) IN OLDER PATIENTS WITH ACUTE MYELOID LEUKEMIA (AML): AZACITIDINE (AZA) VS CONVENTIONAL CARE REGIMENS (CCR) IN THE AZA-AML-001 STUDY

EHA Library, Andre Schuh, 100716

ABSOLUTE QUANTIFICATION OF THE PRETREATMENT PML-RARA MOLECULAR TRANSCRIPT BY DROPLET DIGITAL PCR DEFINES THE RELAPSE RISK IN ACUTE PROMYELOCYTIC LEUKEMIA

EHA Library, Francesco ALBANO, 100717

PREVALENCE AND CLINICAL CHARACTERISTICS OF SETBP1 MUTATIONS IN MYELOID DISORDERS

EHA Library, Nils Winkelmann, 100718

NOTCH1 MUTATIONS ARE ASSOCIATED WITH LOW CD20 EXPRESSION LEVELS IN CHRONIC LYMPHOCYTIC LEUKEMIA: EVIDENCE FOR A NOTCH1-MEDIATED EPIGENETIC MECHANISM

EHA Library, Federico Pozzo, 100719

MYD88 L265P SOMATIC MUTATIONS INFLUENCE GENE EXPRESSION AND THERAPEUTIC RESPONSE IN CHRONIC LYMPHOCYTIC LEUKEMIA

EHA Library, Jennifer R. Brown, 100720

THE GAIN OF THE SHORT ARM OF CHROMOSOME 2 (2P) IN CHRONIC LYMPHOCYTIC LEUKEMIA (CLL) RESULTS IN XPO1 OVEREXPRESSION AND DRUG RESISTANCE.

EHA Library, Adrien Cosson, 100721

A LONGITUDINAL STUDY OF NEXT GENERATION SEQUENCING IN CHRONIC LYMPHOCYTIC LEUKEMIA SHOWS EVIDENCE OF CHEMOTHERAPY-INDUCED MUTAGENESIS AND SNOWBALLING EFFECT DUE TO LOSS OF P53/ATM-MEDIATED DNA REPAIR

EHA Library, Sozan Karim, 100722

TP53 MUTATIONS ARE EARLY EVENTS IN CHRONIC LYMPHOCYTIC LEUKEMIA (CLL) DISEASE PROGRESSION AND PRECEDE CLONAL EVOLUTION TO COMPLEX KARYOTYPES.

EHA Library, Fanny Baran-Marszak, 100724

EXPRESSION OF DNA HYDROXYMETHYLATION-RELATED GENES IS ASSOCIATED WITH PROGNOSIS IN CHRONIC LYMPHOCYTIC LEUKEMIA

EHA Library, Michaël Van Damme, 100725

SF3B1 MUTATIONS AND ALTERATIONS OF FOXP1 TRANSCRIPTION IN CHRONIC LYMPHOCYTIC LEUKAEMIA

EHA Library, Hervé Roudot, 100726

ADDITIONAL TRISOMIES AMONGST PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA CARRYING TRISOMY 12: THE PARTNER CHROMOSOME MAKES A DIFFERENCE

EHA Library, Panagiotis Baliakas, 100727

MUTATIONS IN THE TP53 GENE SHOW FEATURES OF SOMATIC HYPERMUTATION PROCESS WITH PROMINENT DIFFERENCE BETWEEN IGHV MUTATED AND UNMUTATED CHRONIC LYMPHOCYTIC LEUKEMIA

EHA Library, Nikola Tom, 100728

SAFETY OF IDELALISIB IN B-CELL MALIGNANCIES: INTEGRATED ANALYSIS OF EIGHT CLINICAL TRIALS

EHA Library, Steven E Coutre, 100729

PHASE I, FIRST-IN-HUMAN TRIAL OF BI 836826 (AN ANTI-CD37 ANTIBODY) IN PATIENTS (PTS) WITH RELAPSED/REFRACTORY (R/R) CHRONIC LYMPHOCYTIC LEUKEMIA (CLL)

EHA Library, Stephan Stilgenbauer, 100730

TELOMERE LENGTH AND POT1 MUTATIONS IN CLL: INCIDENCE, ASSOCIATIONS ANDCLINICAL IMPACT IN THE COMPLEMENT 1 TRIAL

EHA Library, Billy Michael Chelliah, 100731

PREVALENCE AND CHARACTERISTICS OF CENTRAL NERVOUS SYSTEM (CNS) INVOLVEMENT BY CHRONIC LYMPHOCYTIC LEUKEMIA (CLL)

EHA Library, Paolo Strati, 100732

ARSENIC TRIOXIDE AND ALL-TRANS-RETINOIC ACID TARGET NPM1 MUTANT ONCOPROTEIN LEVELS AND INDUCE APOPTOSIS IN NPM1-MUTATED AML CELLS

EHA Library, Maria Paola Martelli, 100692

RATIONAL TARGETING OF NOTCH SIGNALLING IN ACUTE MYELOID LEUKAEMIA

EHA Library, Paul Takam Kamga, 100691

PRO-METASTASIS PHOSPHATASE PRL-3 TRANSFORMS LEUKEMIA STEM CELLS AND PROMOTES LEUKEMOGENESIS IN AML VIA ACTIVATION OF SOX4/LIN28B/LET-7 SIGNALING

EHA Library, Jianbiao Zhou, 100690

GENOMIC LANDSCAPE OF CORE-BINDING FACTOR ACUTE MYELOID LEUKEMIA

EHA Library, Nicolas Duployez, 100689

LEUKEMOGENIC MLL-ENL FUSIONS INDUCE ALTERNATIVE CHROMATIN STATES TO DRIVE A FUNCTIONALLY DICHOTOMIC GROUP OF TARGET GENES.

EHA Library, Robert Slany, 100688

ADDITIONAL MOLECULAR ABERRATIONS LEADING TO LEUKEMIC TRANSFORMATION IN PATIENTS WITH FAMILIAL PLATELET DISORDER

EHA Library, Nicolas Duployez, 100687

SELECTIVE DEATH OF LEUKEMIC STEM CELLS INDUCED BY DEFERASIROX

EHA Library, Saar Shapira, 100686

NEW JAK2 HETEROZYGOUS LOSS: A ROLE IN OVERALL SURVIVAL IN ACUTE MYELOID LEUKEMIA PATIENTS

EHA Library, Viviana Guadagnuolo, 100685

A DISTINCTIVE LONG-NON CODING RNA SIGNATURE CHARACTERIZES ACUTE MYELOID LEUKEMIA WITH TRANSLOCATION T(8;16)(P11;P13) AND MYST3-CREBBP REARRANGEMENT

EHA Library, Marina Diaz-Beya, 100684

IMPROVED SURVIVAL IN ADULT PATIENTS WITH ACUTE LYMPHOBLASTIC LEUKEMIA (ALL) IN THE NETHERLANDS: A POPULATION-BASED STUDY ON TREATMENT, TRIAL PARTICIPATION AND SURVIVAL, 1989-2012

EHA Library, Aniko Szabo, 100683

SIGNIFICANCE OF RECURRENCE OF MINIMAL RESIDUAL DISEASE (MRD) DETECTED BY MULTI-PARAMETER FLOW CYTOMETRY (MFC) IN PATIENTS WITH ACUTE LYMPHOBLASTIC LEUKEMIA (ALL) IN MORPHOLOGICAL REMISSION

EHA Library, Naveen Pemmaraju, 100682

DEVELOPMENT OF AN NGS ASSAY FOR IGK THAT CAN BE COMBINED WITH IGH FOR IDENTIFYING CLONAL POPULATIONS IN LYMPHOID MALIGNANCIES

EHA Library, Niels Adams, 100681

HDAC EXPRESSION PATTERNS ASSOCIATE WITH HIGH-RISK FEATURES IN PEDIATRIC LEUKEMIA

EHA Library, Mireia Camós, 100680

OSTEONECROSIS IN AIEOP ALL 2000 AND 2006R TRIALS

EHA Library, Rosanna Parasole, 100679

NONE OF THE COMMON RISK FACTORS IS SIGNIFICANT IN T-CELL ACUTE LYMPHOBLASTIC LEUKEMIA TREATED ACCORDING TO NON-INTENSIVE BUT NON-INTERRUPTIVE PROTOCOL ALL-2009: RESULTS OF THE RUSSIAN ALL STUDY GROUP

EHA Library, Elena Parovichnikova, 100678

EXTENSIVE PHENOTYPIC CHARACTERIZATION AND CYTOKINE PRODUCTION OF WHOLE BLOOD AT DAY 29 OF INDUCTION CHEMOTHERAPY FOR PEDIATRIC ACUTE LYMPHOBLASTIC LEUKEMIA

EHA Library, Nina Rolf, 100677

IKZF1 DELETION AND PROGNOSIS OF ADULTS WITH COMMON B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA

EHA Library, Qiu-Mei Yao, 100676

IMPACT OF STEROID DOSE AT INDUCTION PHASE OF PEDIATRIC ALL ON MINIMAL RESIDUAL DISEASE AND SURVIVAL OF THE PATIENTS: A PROSPECTIVE RANDOMIZED STUDY

EHA Library, Sule Unal, 100675

GENOME-WIDE ANALYSIS OF WDR5 BINDING REVEALS ITS EFFECT ON TUMORIGENESIS IN ACUTE LEUKEMIA

EHA Library, Zheng Ge, 100674

PROGNOSIS IN OLDER/ELDERLY PATIENTS WITH ACUTE LYMPHOBLASTIC LEUKAEMIA DIAGNOSED 2005-2012: RESULTS FROM A SWEDISH POPULATION-BASED STUDY

EHA Library, Emma Bergfelt Lennmyr, 100673

A RARE SUBPOPULATION OF QUIESCENT, DRUG RESISTANT STEM CELLS IN PATIENTS' ALL CELLS GROWING IN MICE

EHA Library, Irmela Jeremias, 100672

PATIENT'S SINGLE STEM CELL CLONES OF ACUTE LYMPHOBLASTIC LEUKEMIA SHOW DRUG RESISTANCE AND SLOW PROLIFERATION IN MICE IN VIVO

EHA Library, Cornelia Finkenzeller, 100671

EXPRESSION OF GATA3 DEPENDS ON GENOTYPE VARIANT AT RS3824662 AND IS ASSOCIATED WITH CLINICAL COURSE OF B-CELL CHILDHOOD ACUTE LYMPHOBLASTIC LEUKEMIA

EHA Library, Joanna Madzio, 100670

XIAP EXHIBITS AN ESSENTIAL ROLE FOR PATIENTS’ ALL CELLS GROWING IN VIVO AS SHOWN BY A NOVEL TECHNIQUE FOR STABLE KNOCKDOWN IN PATIENT-DERIVED XENOGRAFT (PDX) ALL CELLS

EHA Library, Michela Carlet, 100669

DISTINCT ALL-ASSOCIATED JAK3 MUTANTS EXHIBIT DIFFERENT CYTOKINE-RECEPTOR REQUIREMENTS AND JAK-INHIBITOR SPECIFICITIES

EHA Library, Elisabeth Losdyck, 100668

INTEGRATED ANALYSIS OF JAK/STAT, RAS/AKT AND NOTCH1 PATHWAYS IN T-CELL ACUTE LYMPHOBLASTIC LEUKEMIA: PROGNOSTIC AND THERAPEUTIC IMPLICATIONS

EHA Library, Valentina Gianfelici, 100667

CLONAL ORIGINS OF HIGH-HYPERDIPLOID ACUTE LYMPHOBLASTIC LEUKEMIA

EHA Library, Donat Alpar, 100666

JAK2 MUTATIONS ARE HIGHLY ENRICHED IN CRLF2-REARRANGED B-ALL CASES WITH A PH-LIKE GENE SIGNATURE

EHA Library, Teresa Sadras, 100665

IL-7 ACTIVATES THE JAK/STAT5/PIM1 KINASE AXIS THEREBY MEDIATING VIABILITY AND GROWTH OF T-CELL ACUTE LYMPHOBLASTIC LEUKEMIA CELLS

EHA Library, Daniel Ribeiro, 100664

MIR-146B IN T-CELL ACUTE LYMPHOBLASTIC LEUKEMIA: A POSSIBLE TUMOR SUPPRESSOR ROLE

EHA Library, Rita Fragoso, 100663

PHARMACOKINETIC/PHARMACODYNAMIC EVALUATION OF AG-120, A POTENT INHIBITOR OF THE IDH1 MUTANT PROTEIN, IN A PHASE 1 STUDY OF IDH1-MUTANT ADVANCED HEMATOLOGIC MALIGNANCIES

EHA Library, Bin Fan, 100713